MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CLDI — Calidi Biotherapeutics, Inc.
NYSE AmericanCalidi Biotherapeutics, Inc.
$1.08
+0.00(+0.00%)
- O
- 1.09
- H
- 1.09
- L
- 1.05
- V
- 38.61K
⏱️ End-of-day dataAs of Oct 2, 2026
CLDI — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | 6,631.00 | 5,600.00 | 10,375.00 | 5,279.00 | 10,561.00 | 9,591.00 |
| Cash And Cash Equivalents | 6,631.00 | 5,600.00 | 10,375.00 | 5,279.00 | 10,561.00 | 9,591.00 |
| Prepaid Assets | 484.00 | 422.00 | 385.00 | 377.00 | 596.00 | 387.00 |
| Other Current Assets | 238.00 | 234.00 | 268.00 | 343.00 | 282.00 | 249.00 |
| Total Current Assets | 7,353.00 | 6,256.00 | 11,028.00 | 6,049.00 | 11,489.00 | 10,227.00 |
| Properties | 1,342.00 | 1,682.00 | 2,012.00 | 2,333.00 | 2,636.00 | 2,934.00 |
| Machinery Furniture Equipment | 2,511.00 | 2,575.00 | 2,561.00 | 2,536.00 | 2,261.00 | 2,224.00 |
| Accumulated Depreciation | -1,753.00 | -1,794.00 | -1,712.00 | -1,607.00 | -1,466.00 | -1,355.00 |
| Other Non Current Assets | 138.00 | 138.00 | 140.00 | 40.00 | 144.00 | 152.00 |
| Total Non Current Assets | 2,238.00 | 2,601.00 | 3,001.00 | 3,302.00 | 3,575.00 | 3,955.00 |
| Total Assets | 9,591.00 | 8,857.00 | 14,029.00 | 9,351.00 | 15,064.00 | 14,182.00 |
| Accounts Payable | 849.00 | 595.00 | 1,143.00 | 1,215.00 | 1,198.00 | 2,072.00 |
| Accrued Expenses | 1,432.00 | 1,806.00 | 840.00 | 658.00 | 1,006.00 | 2,338.00 |
| Short Term Debt | 1,504.00 | 1,516.00 | 1,871.00 | 2,192.00 | 2,453.00 | 4,446.00 |
| Total Current Liabilities | 3,836.00 | 3,935.00 | 5,193.00 | 5,353.00 | 5,426.00 | 9,496.00 |
| Long Term Debt | 753.00 | 1,048.00 | 1,437.00 | 1,819.00 | 2,252.00 | 2,590.00 |
| Derivative Product Liabilities | 67.00 | 115.00 | 201.00 | 103.00 | 87.00 | 128.00 |
| Total Non Current Liabilities | 820.00 | 1,163.00 | 1,638.00 | 1,922.00 | 2,339.00 | 2,718.00 |
| Total Liabilities | 4,656.00 | 5,098.00 | 6,831.00 | 7,275.00 | 7,765.00 | 12,214.00 |
| Common Stock | 1.00 | 1.00 | 1.00 | 0.00 | 3.00 | 2.00 |
| Retained Earnings | -145,729.00 | -141,621.00 | -137,565.00 | -132,416.00 | -126,701.00 | -121,715.00 |
| Other Shareholders Equity | -22.00 | -13.00 | -13.00 | -13.00 | -26.00 | -28.00 |
| Total Shareholders Equity | 4,935.00 | 3,759.00 | 7,198.00 | 2,076.00 | 7,299.00 | 1,968.00 |
| Additional Paid In Capital | 150,685.00 | 145,392.00 | 144,495.00 | 134,193.00 | 133,665.00 | 123,275.00 |
| Minority Interest | N/A | 0.00 | 280.00 | 312.00 | 358.00 | 434.00 |
| Pensions | N/A | N/A | 1,334.00 | 1,276.00 | 762.00 | N/A |
| Other Receivables | N/A | N/A | N/A | 50.00 | 50.00 | N/A |
| Provision For Risks And Charges | N/A | N/A | N/A | N/A | N/A | 0.00 |